Sofinnova Investments, Inc. - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$233,538,484
-22.0%
1,381,1490.0%14.73%
-24.9%
Q2 2023$299,502,161
-7.0%
1,381,149
-22.1%
19.62%
-4.8%
Q1 2023$322,070,243
-20.9%
1,773,124
-14.5%
20.60%
-14.8%
Q4 2022$407,368,867
-12.6%
2,073,1240.0%24.17%
-10.9%
Q3 2022$466,308,000
+77.8%
2,073,1240.0%27.13%
+24.2%
Q2 2022$262,271,000
+5.9%
2,073,124
+6.1%
21.84%
+16.2%
Q1 2022$247,631,000
-3.2%
1,953,0770.0%18.79%
+25.8%
Q4 2021$255,853,000
+7.1%
1,953,0770.0%14.94%
+5.6%
Q3 2021$238,920,000
+7.4%
1,953,077
+0.0%
14.15%
+10.3%
Q2 2021$222,559,000
-5.2%
1,952,4410.0%12.83%
-9.1%
Q1 2021$234,742,000
+18.3%
1,952,4410.0%14.11%
+19.5%
Q4 2020$198,348,000
+31.4%
1,952,4410.0%11.81%
+5.5%
Q3 2020$150,963,000
-28.2%
1,952,441
+3.5%
11.19%
-15.5%
Q2 2020$210,169,000
+54.8%
1,885,6020.0%13.25%
+5.5%
Q1 2020$135,763,000
-4.4%
1,885,6020.0%12.56%
+22.6%
Q4 2019$142,061,000
+403.4%
1,885,602
+9.0%
10.24%
+301.3%
Q3 2019$28,223,000
-18.5%
1,729,3520.0%2.55%
-19.8%
Q2 2019$34,622,0001,729,3523.18%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,952,441$150,963,00011.19%
Eventide Asset Management 901,077$69,671,0001.36%
First Light Asset Management, LLC 128,200$9,912,0001.02%
Prosight Management, LP 15,826$1,224,0000.58%
MOODY ALDRICH PARTNERS LLC 30,970$2,395,0000.50%
PFM Health Sciences, LP 137,960$10,667,0000.49%
Rock Springs Capital Management LP 244,106$18,874,0000.48%
Atika Capital Management LLC 73,500$5,683,0000.46%
Hood River Capital Management LLC 132,400$10,237,0000.44%
CATALYST PRIVATE WEALTH, LLC 5,006$387,0000.38%
View complete list of KARUNA THERAPEUTICS INC shareholders